Reprogramming Macrophage by Targeting VEGF and CD40 Potentiates OX40 Immunotherapy

To explore the mechanism underlying the action of anti-OX40 agonists to improve the anti-tumor efficacy, scientists analyzed the dynamic changes of tumor-infiltrating immune cells at different days post-treatments using single-cell RNA-sequencing.